A more affordable, lower-risk polio vaccine is on the horizon, research led by the University of Leeds has found.

As the measles outbreak in the U.S. spreads, experts fear that other preventable diseases, including polio, rubella, and mumps, could return. Here’s what you can do to stay safe.

In a paper published in Nature Communications, the findings show that VLPs produced in both yeast and insect cells can perform equally or better than the current inactivated polio vaccine (IPV ...

Nobody complains that we have more cancer medicines available today than in the 1980s. Why should we complain about having ...

US-based PharmaJet, a company dedicated to enhancing injectable performance through needle-free injection technology, has ...

University of Leeds researchers have taken a major step towards producing a more affordable and lower-risk polio vaccine using virus-like particles (VLPs). These particles mimic the outer protein ...

Scientists Harness Bile-Converting Bacteria to Heal Damaged ColonsThe human gut is home to trillions of bacteria that play ...

The last recorded case of polio was in 1989 ... drop), provided they have already received three doses of Inactivated Polio Vaccine (IPV) of the basic scheme. So far, about six million doses ...

Tropis was used to deliver fractional dose inactivated polio vaccine (fIPV) in parallel to oral polio vaccine (OPV) administration as part of a WHO recommended strategy to boost humoral immunity.

adherence to UNICEF guidelines in the rest of the world is driving steady demand for both oral polio vaccine (OPV) and inactivated polio vaccine (IPV). Manufacturers are scaling up production and ...